The number of clone types and oligoclonality were calculated for each sample, with non-CR groups having more clone types and showing a decreasing trend in oligoclonality after treatment (Fig. 3B ).
← all excerpts
The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma.
1
—
—